Gravitas Biosciences Health provide comprehensive pharmacovigilance consulting services to help you tackle all strategic challenges on your route to successful drug discovery. Leveraging our deep institutional knowledge and automated process, we bring all the relevant drug discovery information to your table to help you advance your drug discovery cycle, effectively manage drug development processes and deliver solutions that help improve patients’ lives.
We help you effectively manage and maintain the safety and accuracy of drug discovery clinical trials, right from Phase 1 to Phase 4. From helping you score the emerging trends to evaluate ongoing research trials and highlight potential compliance issues, our pharmacovigilance experts make sure you have all the information in place for quicker drug discovery and improved patient safety.
Pharmacovigilance experts at Gravitas Biosciences Health provide comprehensive drug safety services to minimize the adverse effects of drug trials in clinical trial participants. Through versatile technologies and intelligent data analysis capabilities, we help companies access the safety and efficacy of their drugs. From collecting sophisticated drug safety data to in-depth analysis and reporting, our comprehensive patient safety services help pinpoint all the potential drug safety concerns early-on.
Our end-to-end compliance regulatory technologies and advisory services help you create an intelligent, integrated approach for compliance management. By reviewing and auditing your current drug discovery processes and identifying gaps and compliance issues, we help you effectively meet all the national and international regulatory requirements.
We also offer serious adverse effect (SAE) case handling and regulatory intelligence services so that you can review and manage the evolving safety profile of your product throughout the drug development process. Our regulatory intelligence allows us to ensure that your product meets all the rules and regulations set by the regulatory committees.